Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Language
Document Type
Year range
1.
AJPM Focus ; : 100040, 2022.
Article in English | ScienceDirect | ID: covidwho-2068989

ABSTRACT

Introduction: Previous studies have identified numerous adverse events experienced with use of electronic nicotine delivery systems (ENDS), or e-cigarettes. Much remains unknown, however, about adverse event frequency, duration, and response experienced by users. The purpose of this study was to inductively characterize ENDS-attributed adverse events among young adults. Methods: Sixteen focus groups were held with 114 young adults (18-29 years) who have reported lifetime ENDS use in April 2021. Discussion topics included current and previous tobacco, nicotine, and cannabis use;specific symptoms and frequency and duration of and response to symptoms ENDS-attributed adverse events;and the impact of other conditions such as COVID-19 on ENDS use. Data were inductively analyzed using a team-based approach. Results: Over 40 ENDS-attributed adverse events were reported in focus groups among approximately three-quarters of all study participants with headache, coughing, lightheadedness, nausea, dry or sore throat, and dizziness the most common. In general, adverse events were transient with most resolving in a few hours though some tended to last for longer. Frequency of adverse events varied most between every time ENDS were used and when someone vaped excessively. Finally, behavioral responses varied by adverse event with difficulty breathing, chest pain, and lung discomfort more likely to result in quitting permanently. Conclusions: Overall, the results of this study show that not only do adverse events vary greatly, but that they also vary across all multiple dimensions of user experience.

SELECTION OF CITATIONS
SEARCH DETAIL